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Abstract
Quality measurements (QMs) have emerged as quantitative tools for measuring “quality”, an
elusive term that has been historically difficult to define and quantify. However, current
literature has demonstrated that these measurements are flawed. The purpose of this study was
to identify the strengths and weaknesses of quality measurements and provide a novel
scorecard for evaluating quality measurements. In this retrospective analysis, 246 quality
measurements that are integrated into the most significant payer-provider contracts within our
institution were analyzed. Each measurement was dissected based on type of measurement,
evidence, precision, data exchange, alignment, and how patient-oriented. Our research showed
a significant lack of quality measurement alignment across payer-provider contracts. As such,
we developed and proposed a Quality Measurement Evaluation Tool (QMET) that scores a
quality measurement’s ability to 1) reflect population health and 2) promote patient-oriented
goals. Our research demonstrated the majority of quality measurements scored in the
inadequate range (i.e., QMET score <6) and only few in the optimal range (i.e., QMET score 1012). QMET provides a standardized and comprehensive method for appraising quality
measurements, promoting continued use of QMs that accurately reflect population health and
promote patient-oriented measurements. Future research into the application and reliability of
QMET is needed.
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For decades, health care organizations have struggled to measure “quality” - an elusive term
that has been historically difficult to define and quantify. More recently, quality measurements
(QMs) have emerged as quantitative tools for measuring quality and have been widely adopted
by providers, hospitals, and health care systems across the country [1]. However, previous
research demonstrates that these measurements are flawed, often struggling to adequately
measure quality due to shortcomings in several key areas, such as data collection and clinical
evidence [1-5]. Our study analyzes these key areas within our own organization and provides
examples of such shortcomings. Furthermore, our study proposes a novel patient-oriented
scorecard for reproducible analysis of quality measurements. The scale emphasizes the need for
a movement towards patient-oriented quality measurements, a concept that is
underrepresented and undervalued [5]. The ultimate goal of our study is to encourage adoption
of patient-oriented quality measurements, which aim to understand and evaluate the definition
of “quality” from the patient’s perspective.
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Materials And Methods
This was a retrospective analysis of 246 quality measurements within a single metropolitanarea institution in Pennsylvania. Since 1993, our institution’s non-for-profit subsidiary
includes 700+ physicians within 45 diverse medical specialties throughout 160 offices in
Allentown and Bethlehem, Pennsylvania. There are over 50 payer-provider contracts within this
institution, and quality measurements are integrated into these contracts [6]. To further
understand the connection between quality metrics and patient-oriented care, this research
analyzes the 10 largest contracts within this network. Each measurement within these contracts
was dissected based on type of measurement, evidence, precision, data exchange, and
alignment. More detailed definitions of these categories are shown in Table 1.

Term

Definition

Measurement Whether a measurement is based on a series of actions that lead to a potential health benefit (process) or
Type
a measurement based on quantitative results (outcome).
Precision

A measurement with appropriate numerators/denominators, with proper exclusions and inclusions.

Data

Data shared from payer to provider or vice versa (unidirectional), or equal exchange of data between

Exchange

payer and provider (bidirectional).

Evidence

Measurement with clear evidence to support its validity (e.g., USPSTF Grade A or B; ACC/AHA highmoderate level evidence).

Alignment

Prevalence of measurement among payers (i.e., percentage of payers using given measurement).

PatientOriented

Measurement is of direct value to the patient (e.g., preventing vision loss or stroke).

TABLE 1: Definitions Key

Results
Type of measurement
Our study categorizes the quality measurements into three types: surrogate outcomes, process,
or mixed. Definitions and examples of each category are shown in Table 2. Of the 246 quality
measurements, there are 192 process measures, 42 surrogate outcome measures and 12 mixed
measures. This breakdown demonstrates the focus on measuring quality through process
measures as opposed to surrogate outcomes or mixed measures. Using process or mixed
outcomes does not adequately portray the health of this patient population. These
measurements help form attainable goals for physician groups, but cannot accurately assess
the health of their patients. Not only are majority of these quality measurements non-outcome
based, the measurements that are outcome-based are only intermediate outcomes and are not
patient-oriented. If a quality measurement was truly measuring what is important to the
patient’s health, then it should not measure the quantitative values in their patient charts, but
the symptomatic changes they live with. For example, it should not be measuring how many
individuals have an HbA1c <9% or percentage of women who had a mammogram to screen for
breast cancer within the past 24 months, but instead should be measuring how many of their
diabetic patients have retinopathy and percentage of individuals with breast cancer with poor
quality of life [7,8]. There are some measurements that are ‘mixed’, such as measuring
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individuals with diabetes who received a retinal or dilated eye exam or a negative exam in the
year prior [9]. Only if these changes were made would we have patient-oriented quality
measurements.

Type of
Measurement

Definition

Example

Quantitative results that have
Surrogate

a measurable value related to

Percentage of patients aged 18 to 75 years of age with diabetes

Outcome

a treatment modality or
preventative care

mellitus who had HbA1c ⪯ 9% [7].

Measurement of a series of
Process

actions that lead to a potential
health benefit
The combination of both a

Mixed

process and a surrogate
outcome

Percentage of women aged 40 to 69 years who had a mammogram to
screen for breast cancer within 24 months [8].
Percentage of members 18-75 years of age with diabetes (type 1 and 2)
who received a retinal or dilated eye exam during the measurement
year or a negative retinal or dilated eye exam in the year prior to the
measurement year [8,9].

TABLE 2: Type of Measurement

Evidence
The adoption of quality measurements is based upon clinical evidence and support from
national criteria, such as the United States Preventive Service Task Force (USPSTF). However,
our research indicates that while a large percentage of QMs are evidence-driven, a substantial
portion of QMs is driven by payer data and/or expertise. For example, cervical cancer screening
is strongly evidence-based as it measures the number of female patients aged 21 to 65 years
who received cervical cytology in the past three years, a criteria endorsed by USPSTF and
supported in clinical literature [10-11]. Conversely, quality measurements that monitor
comprehensive control of diabetes do so by measuring the percentage of diabetic patients that
received low-density lipoprotein (LDL) testing in the last year. There is limited clinical
evidence to support the efficacy of these measurements, and national agencies do not support
the claim that these measurements improve quality. As such, the failure of quality
measurements to be both evidence-based and improve quality once again brings up the
question of patients’ values. Patient-oriented quality measurements should have clinical
evidence to support their efficacy in improving patient care and outcomes; otherwise, they are
of no benefit to the patient.

Precision
QMs are quantified by a ratio: a numerator consisting of the number of patients appropriately
meeting the measurement divided by a denominator of every patient that qualifies for the
measurement. For QMs to reflect population health, it is essential that the way they are
quantified is also precise. An example of a precise QM is prescribing controller medications for
asthma. Asthma severity is clearly defined in medical practice, and providers prescribe
controller medications according to severity - there is little variation in asthma management
across providers or payers [12]. However, our research indicates that certain measurements are
imprecise, such as cervical cancer screening. When measuring cervical cancer screening,
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multiple payers define the denominator as “women 24-64 years as of the last measurement
year”; however, it does not exclude women who have a history of a hysterectomy, invalidating
the denominator and reducing the measurement’s precision [12].
Furthermore, transfer and leakage are two other causes of poor precision. Transfer is the
movement of patients between payers. Our research indicates that a patient with a prior
hysterectomy, when transferred into this network, is inappropriately included in the
denominator due to non-transferrable payer codes. The work-around for this problem is to
manually input the appropriate code; however, this extra step is rarely carried out, leaving the
patient in the denominator and skewing the data. Secondly, leakage causes further inaccuracies.
For instance, the quality measurement on diabetic eye exam screenings has been especially
difficult for this network. This measurement requires patients with diabetes from age 18 to 75
years old to receive an eye screening for retinal disease [9]. Unfortunately, patients often travel
out-of-network and are missed by our network, resulting in improper reimbursements and
inaccurate population data [13].
Our research demonstrates the shortcomings in properly defining quality measurements. This
challenges the success of quality measurements in reflecting quality and population health. The
lack of a standard procedure for creating quality measurements - or a method for revising their
flaws - results in an inability of providers to tailor medical services. This inability hinders the
movement toward the goal of patient-oriented quality measurements.

Data exchange
Our research also pinpoints several other areas in which quality measurements struggle to
accurately measure the quality of health care systems. For example, electronic medical record
(EMR) systems - in their current form - have barriers to inputting data and properly
documenting patient information. For example, this institution’s EMR system can only query
data for diabetic foot exams if it is placed in a particular field and will not be queried if it is
written in narrative form, which deflates the rate of diabetic foot exams.
Furthermore, this network utilized three types of data extraction: insurance claims, clinical
reports, and self-reporting. These different forms of data distribution result in the
unidirectional (i.e., from payer to provider or vice versa) or bidirectional (i.e., equal exchange of
data between payer and provider) sharing of data. For example, the QM measuring body mass
index (BMI) is bidirectional as the provider shares its clinical data with the payer and the payer
shares its claims data with the provider. The QM measuring diabetic foot exams is
unidirectional as only the provider shares clinical data collected on foot exams to the payer. In
the future, every provider-payer relationship should adapt to shift the culture from
unidirectional data exchange to bidirectional data exchange in order to best assess population
health. Without this shift, the healthcare system will continue to fail to reflect population
health simply due to a lack of communication between providers and payers.

Alignment
Arguably the greatest issue facing quality measurements is the lack of alignment. This research
finds significant variation in type of measurement, evidence, precision, and data exchange. Of
the 246 QMs analyzed in this study, there were only three quality measurements that were
utilized by more than 75% of payers. ‘Breast Cancer Screening’ is an example of a quality
measurement with strong alignment as it was standardized across 77% of the payers within this
study. On the other hand, ‘Fall Risk Assessment for Older Adults’ is a quality measurement that
is included in only 31% of contracts. This misalignment of quality measurements across payers
is unacceptable when considering the goal of patient-oriented quality care. Significant
improvement is needed in order to provide patients with quality care that is uniform across
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payers, such that patients can maneuver between insurance plans without concern for drastic
changes in quality.

Limitations
This analysis was limited by the nature that it was retrospective. The analysis was also limited
to one health network, and thus might not apply to all networks in various locations. The
analysis was also only completed on select payers within the network, therefore, may not apply
to all payers.

Discussion
Our solution to the issue of alignment is a novel scoring system for objectively grading quality
measurements. Quality Measurement Evaluation Tool (QMET), shown in Table 3, is a 12-point
scoring system that evaluates quality measurements based on the areas described in our study.
Further examples of each category are listed in Table 4. The scoring criteria is as such that less
than six points is an inadequate measurement (i.e., should be revised or reconsidered), six to
seven points is a mediocre measurement (i.e., should be re-evaluated for efficacy), eight to nine
points is an adequate measurement (i.e., should be used for internal quality improvement), and
ten to twelve points is an optimal measurement (i.e., should be used for universal quality
improvement).

Factor
Measurement

Score

Subtotal

0 - Process measurement

1 - Mixed measurement

2 - Outcome measurement

__/2

Precision

0 - Not precise

1 - Precise but exclusions
need further definition

2 - Precisely defined with
proper exclusion

__/2

Evidence

0 - No evidence or minimal
evidence

1 - Contradicting or
controversial evidence

2 - Clear and consistent
evidence

__/2

Data
Exchange

0 - Unidirectional (payer to
provider OR provider to payer)

Type

Alignment
PatientOriented

2 - Bidirectional (payer to
provider AND provider to
payer)

0 - QM is used in less than

1 - QM is used in 50-74%

2 - QM is used in at least 75%

50% of insurance contracts

of insurance contracts

of insurance contracts

0 - Not patient-oriented

1 - Limited or questionable
2 - Patient-oriented
value for patient
Total:

__/2

__/2

__/2
__/12

TABLE 3: Quality Measurement Evaluation Tool (QMET)
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Data

Measurement

Precision

Evidence

Type Score

Score

Score

Diabetic Foot Exams

0

2

1

0

0

Colorectal Cancer Screening

0

2

1

2

2

2

2

2

Quality Measurement

Exchange
Score

Alignment

Patient-

Total

Qualitative

Score

Analysis

0

3/12

Inadequate

2

1

8/12

Adequate

2

2

12/12

Optimal

Score

Oriented
Score

Hospital Consumer
Assessment of Healthcare
Providers and Systems
(HCAHPS)

TABLE 4: Example Evaluations

Colorectal cancer screening scores 8/12 due to strong performances in the areas of alignment,
precision, evidence, and how patient-oriented. HCAHPS receives a perfect score and serves as
an example of an optimal quality measurement; however, our study finds few quality
measurements that meet these criteria, demonstrating the significant need for further
development.
QMET focuses on two important elements of quality measurements: population health and
patient-oriented goals. The first four factors listed in the scale - measurement type, precision,
evidence, and data exchange - emphasize the importance of utilizing quality measurements
that fulfill the requirement necessary to reflect population health. Fulfilling these requirements
allows quality measurements to accurately measure and analyze population health. It also
provides healthcare organizations with data to help drive organizational decisions that will best
improve the health of their patients. QMET helps achieve the original goal of quality
measurements, which is to advance the quality of our healthcare system. Patient-oriented
quality measurements position the patient at the center of how we define quality. They are
respectful and responsive to the individual needs, values, and preferences of each patient. The
success of each measurement is linked to how well it meets the patient’s own definition of
quality [14]. This is a dramatic shift away from our previous understanding of quality, which
focused predominantly on population health and provider performance.

Conclusions
Our research analyzes the failure of quality measurements to accurately represent population
health and promote patient-oriented goals. These failures are derived from shortcomings in the
following domains: measurement type, precision, evidence, data exchange, and alignment. We
propose Quality Measurement Evaluation Tool (QMET) as a method for evaluating and
critiquing quality measurements. QMET provides a reproducible and objective tool for choosing
which quality measurements need reconsideration, revision, or are ready for implementation.
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